Safety and Efficacy of Palonosetron IV to Prevent Postoperative Nausea and Vomiting in Pediatric Patients
Status:
Completed
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the efficacy of a single palonosetron IV
dose compared to a single ondansetron IV dose in the prevention of postoperative nausea and
vomiting through 24 hours after surgery in children aged from neonates up to less than 17
years undergoing elective surgical procedures requiring general intravenous anesthesia. The
secondary objective is to evaluate the safety and tolerability of IV palonosetron in
pediatric patients.